[ Outset Medical raises $76.5M in Series C funding ]

Outset Medical has raised $76.5 million in Series C funding.

Founded in 2003, Outset Medical is a pioneering medical technology company that always puts the patient before the machine. Outset’s technology, the Tablo™ Hemodialysis System, is the first novel dialysis system to reach the U.S. market in more than 15 years. The system can be used flexibly across a range of clinical settings from dialysis clinics to hospitals and skilled nursing facilities.

The company will use proceeds from the financing to expand the commercial introduction of the Tablo System in acute and chronic care markets in the United States.

Funding  Series C
Founded  2003
Country  USA
City  San Jose, California
Founder / CEO  Leslie Trigg
Deal Size  $76.5M
Investors  T. Rowe Price
 The Vertical Group
 Perceptive Advisors
 Partner Fund Management
 Warburg Pincus
 Fidelity Management and Research Company
Previous Investors  CRG L.P.
 Perceptive Advisors
 Partner Fund Management
The Vertical Group
 The Vertical Group

[adyen action=”checkout_button”]